Park Square Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Park Square Financial Group's REGN Position: Q2 2026 in Review
Park Square Financial Group opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 2 shares worth $1.25K. The stake represents 0.01% of the portfolio and ranks #192 among its holdings. This is a return to the name: Park Square Financial Group previously reported a position in REGN as recently as Q4 2025.
Park Square Financial Group first reported a position in REGN in Q4 2024 and has held it in 5 quarters since. The position peaked at $181K in Q1 2025. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Park Square Financial Group held 2 shares of Regeneron Pharmaceuticals worth $1.25K as of Q2 2026.
- Regeneron Pharmaceuticals was a new Park Square Financial Group position in Q2 2026.
- Regeneron Pharmaceuticals made up 0.01% of Park Square Financial Group's portfolio in Q2 2026, its #192 holding.
- Park Square Financial Group first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
- Park Square Financial Group's Regeneron Pharmaceuticals position peaked at $181K in Q1 2025.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Park Square Financial Group's 13F filing for Q2 2026, filed 31 Jul 2026.